ロード中...
Towards a commercial process for the manufacture of genetically modified T cells for therapy
The recent successes of adoptive T-cell immunotherapy for the treatment of hematologic malignancies have highlighted the need for manufacturing processes that are robust and scalable for product commercialization. Here we review some of the more outstanding issues surrounding commercial scale manufa...
保存先:
| 出版年: | Cancer Gene Ther |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356749/ https://ncbi.nlm.nih.gov/pubmed/25613483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2014.78 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|